TokenPost·
Madrigal Plans MASH Cirrhosis Trial With More Than 2,000 Patients for 2027
The planned Phase 3 MAESTRO-CSPH study is targeted to start in the first half of 2027, pending regulatory discussions. Madrigal expects results in the early 2030s.
More news
- TokenPostOsmosis Community Pool Loses 55.5 Million OSMO in Token Burn
- TokenPostMaple Signals Tokenized Assets as a Focus for Credit Underwriting
- Crypto BriefingBofA’s Cabana: Too soon to declare end of Fed’s rate hikes in 2026
- DecryptSam Altman Says It's 'Fucking Annoying' His RAM Comments Were Taken Out of Context
- Crypto BriefingThailand to block Bitget access from Dec. 5 after SEC complaint
- CointelegraphBlockchain is ‘perfect solution’ for AI agent trust, VeChain CEO says